Cytokine pathway variants modulate platelet production: IFNA16 is a thrombocytosis susceptibility locus in humans.

MLA

Gnatenko, Dmitri V., et al. “Cytokine Pathway Variants Modulate Platelet Production: IFNA16 Is a Thrombocytosis Susceptibility Locus in Humans.” Blood Advances, vol. 6, no. 16, Aug. 2022, pp. 4884–900. EBSCOhost, https://doi.org/10.1182/bloodadvances.2021005648.

APA

Gnatenko, D. V., Liu, Z., Hearing, P., Sohn, S.-Y., Hu, Y., Falanga, A., Wu, S., Malone, L. E., Zhu, W., & Bahou, W. F. (2022). Cytokine pathway variants modulate platelet production: IFNA16 is a thrombocytosis susceptibility locus in humans. Blood Advances, 6(16), 4884–4900. https://doi.org/10.1182/bloodadvances.2021005648

Chicago

Gnatenko, Dmitri V, Zhaoyan Liu, Patrick Hearing, Sook-Young Sohn, Yetao Hu, Anna Falanga, Song Wu, Lisa E Malone, Wei Zhu, and Wadie F Bahou. 2022. “Cytokine Pathway Variants Modulate Platelet Production: IFNA16 Is a Thrombocytosis Susceptibility Locus in Humans.” Blood Advances 6 (16): 4884–4900. doi:10.1182/bloodadvances.2021005648.